Compare Tata India Pharma & Healthcare Fund vs UTI Healthcare Fund
Tata India Pharma & Healthcare Fund
EquitySectoral-Pharma
UTI Healthcare Fund
EquitySectoral-Pharma
Risk
Very High
Very High
Rating
2.0
4.0
Min SIP Amount
₹100
₹500
Expense Ratio
2.42
2.23
NAV
₹35.75
₹354.64
Fund Started
04 Dec 2015
01 Aug 2005
Fund Size
₹1511.49 Cr
₹1429.84 Cr
Exit Load
Exit load of 0.25% if redeemed within 30 days.
Exit load of 1% if redeemed within 30 days.
1 Year
-2.97%
5.98%
3 Year
15.12%
19.93%
5 Year
11.85%
13.58%
Equity
99.72%
94.12%
Cash
0.28%
5.85%
Top 10 Holdings
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 7.99% |
Abbott India Ltd. | 5.94% |
Healthcare Global Enterprises Ltd. | 5.92% |
Divi's Laboratories Ltd. | 5.68% |
Dr. Reddy's Laboratories Ltd. | 4.65% |
Apollo Hospitals Enterprise Ltd. | 4.36% |
Rainbow Children's Medicare Ltd. | 4.30% |
Cipla Ltd. | 4.22% |
Torrent Pharmaceuticals Ltd. | 3.76% |
Max Healthcare Institute Ltd. | 3.71% |
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 7.62% |
Divi's Laboratories Ltd. | 6.15% |
Dr. Reddy's Laboratories Ltd. | 5.24% |
Ajanta Pharma Ltd. | 4.81% |
Gland Pharma Ltd. | 4.06% |
Alkem Laboratories Ltd. | 3.70% |
Apollo Hospitals Enterprise Ltd. | 3.03% |
Caplin Point Laboratories Ltd. | 3.02% |
Global Health Ltd. | 2.96% |
Lupin Ltd. | 2.89% |
Name
-
-
Start Date
-
-
Description
The scheme seeks long term capital appreciation by investing atleast 80% of it's net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.
The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector.
Launch Date
04 Dec 2015
01 Aug 2005
